{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:12:12Z","timestamp":1777630332905,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["21\/12\/2014"],"award-info":[{"award-number":["21\/12\/2014"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.lfs.2020.118291","type":"journal-article","created":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T18:59:57Z","timestamp":1597517997000},"page":"118291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["T-type calcium channel antagonist, TTA-A2 exhibits anti-cancer properties in 3D spheroids of A549, a lung adenocarcinoma cell line"],"prefix":"10.1016","volume":"260","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7547-0950","authenticated-orcid":false,"given":"Neema","family":"Kumari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anamika","family":"Bhargava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subha Narayan","family":"Rath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2020.118291_bb0005","doi-asserted-by":"crossref","first-page":"220","DOI":"10.21037\/tlcr.2018.05.06","article-title":"The epidemiology of lung cancer","volume":"7","author":"de Groot","year":"2018","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.lfs.2020.118291_bb0010","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/JTO.0b013e3181b44321","article-title":"Differential expression of biomarkers in primary non-small cell lung cancer and metastatic sites","volume":"4","author":"Gomez-Roca","year":"2009","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lfs.2020.118291_bb0015","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4103\/2278-330X.187571","article-title":"Lung cancer in the Indian subcontinent","volume":"5","author":"Noronha","year":"2016","journal-title":"South Asian J. Cancer"},{"key":"10.1016\/j.lfs.2020.118291_bb0020","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3389\/fonc.2018.00267","article-title":"Drug resistance in non-small cell lung cancer: a potential for NOTCH targeting?","volume":"8","author":"Sosa Iglesias","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2020.118291_bb0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bgm.2014.07.002","article-title":"Identifying the invasive nature of a distinct population from A549 adenocarcinomic lung cancer cell","volume":"6","author":"Lin","year":"2014","journal-title":"Biomark. Genomic Med."},{"key":"10.1016\/j.lfs.2020.118291_bb0030","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1016\/j.bmc.2018.06.040","article-title":"Indenone derivatives as inhibitor of human DNA dealkylation repair enzyme AlkBH3","volume":"26","author":"Nigam","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.lfs.2020.118291_bb0035","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.bbrc.2013.03.008","article-title":"A multicellular 3D heterospheroid model of liver tumor and stromal cells in collagen gel for anti-cancer drug testing","volume":"433","author":"Yip","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2020.118291_bb0040","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/10463356.2010.11883480","article-title":"3D matrices for anti-cancer drug testing and development","volume":"25","author":"Gurski","year":"2010","journal-title":"Oncol. Issues"},{"key":"10.1016\/j.lfs.2020.118291_bb0045","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cell.2007.08.006","article-title":"Modeling tissue morphogenesis and cancer in 3D","volume":"130","author":"Yamada","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2020.118291_bb0050","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jbiosc.2014.01.008","article-title":"Observation of ovarian cancer stem cell behavior and investigation of potential mechanisms of drug resistance in three-dimensional cell culture","volume":"118","author":"Chen","year":"2014","journal-title":"J. Biosci. Bioeng."},{"key":"10.1016\/j.lfs.2020.118291_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092248","article-title":"Three-dimensional lung tumor microenvironment modulates therapeutic compound responsiveness in vitro \u2013 implication for drug development","volume":"9","author":"Ekert","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.118291_bb0060","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.3892\/or.2015.3767","article-title":"Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer","volume":"33","author":"Imamura","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.lfs.2020.118291_bb0065","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.3748\/wjg.14.4984","article-title":"Calcium signaling and T-type calcium channels in cancer cell cycling","volume":"14","author":"Taylor","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2020.118291_bb0070","doi-asserted-by":"crossref","first-page":"10824","DOI":"10.1074\/jbc.M108754200","article-title":"Overexpression of an alpha 1H (Cav3.2) T-type calcium channel during neuroendocrine differentiation of human prostate cancer cells","volume":"277","author":"Mariot","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2020.118291_bb0075","doi-asserted-by":"crossref","first-page":"27130","DOI":"10.1074\/jbc.M501625200","article-title":"Ca 2+ influx through L-type Ca 2+ channels controls the trailing tail contraction in growth factor-induced fibroblast cell migration","volume":"280","author":"Yang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2020.118291_bb0080","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/cancers11020134","article-title":"T-type calcium channels in cancer","volume":"11","author":"Antal","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.lfs.2020.118291_bb0085","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.lfs.2017.12.033","article-title":"Cardiac voltage gated calcium channels and their regulation by \u03b2-adrenergic signaling","volume":"194","author":"Kumari","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2020.118291_bb0090","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1158\/0008-5472.CAN-17-3061","article-title":"T-type Ca 2+ channels: T for targetable","volume":"78","author":"Sall\u00e1n","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2020.118291_bb0095","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1124\/mol.62.2.210","article-title":"The Ca 2+ channel antagonists mibefradil and pimozide inhibit cell growth via different cytotoxic mechanisms","volume":"62","author":"Bertolesi","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.lfs.2020.118291_bb0100","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009147","article-title":"Calcium channel blockers and cancer: a risk analysis using the UK Clinical Practice Research Datalink (CPRD)","volume":"6","author":"Grimaldi-Bensouda","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.lfs.2020.118291_bb0105","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0895-7061(96)00186-0","article-title":"Do calcium channel blockers increase the risk of cancer?","volume":"9","author":"Pahor","year":"1996","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.lfs.2020.118291_bb0110","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/1060028018814684","article-title":"Calcium channel blockers and the risk for lung cancer: a population-based nested case-control study","volume":"53","author":"Rotshild","year":"2019","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.lfs.2020.118291_bb0115","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1124\/jpet.110.171058","article-title":"In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice","volume":"335","author":"Kraus","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.lfs.2020.118291_bb0120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0022-1759(86)90183-3","article-title":"An improved colorimetric assay for interleukin 2","volume":"93","author":"Tada","year":"1986","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.lfs.2020.118291_bb0125","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1111\/j.1582-4934.2012.01545.x","article-title":"Osteoinduction and survival of osteoblasts and bone-marrow stromal cells in 3D biphasic calcium phosphate scaffolds under static and dynamic culture conditions","volume":"16","author":"Rath","year":"2012","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.lfs.2020.118291_bb0130","series-title":"ImageJ","author":"Rasband","year":"1997"},{"key":"10.1016\/j.lfs.2020.118291_bb0140","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/cancers9050048","article-title":"Targeting intracellular calcium signaling ([Ca2+]i) to overcome acquired multidrug resistance of cancer cells: a mini-overview","volume":"9","author":"B\u00fcsselberg","year":"2017","journal-title":"Cancers"},{"key":"10.1016\/j.lfs.2020.118291_bb0145","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3390\/cancers11020145","article-title":"Calcium signaling in brain cancers: roles and therapeutic targeting","volume":"11","author":"Maklad","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.lfs.2020.118291_bb0150","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.canlet.2008.03.032","article-title":"Selective blockade of T-type Ca2+ channels suppresses human breast cancer cell proliferation","volume":"267","author":"Taylor","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2020.118291_bb0155","series-title":"Calcium Signal. Dis","first-page":"405","article-title":"Calcium signalling and cancer cell growth","author":"Capiod","year":"2007"},{"key":"10.1016\/j.lfs.2020.118291_bb0160","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ceca.2006.04.029","article-title":"T-type calcium channels and tumor proliferation","volume":"40","author":"Panner","year":"2006","journal-title":"Cell Calcium"},{"key":"10.1016\/j.lfs.2020.118291_bb0165","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/bph.12486","article-title":"Calcium influx pathways in breast cancer: opportunities for pharmacological intervention: calcium influx in breast cancer","volume":"171","author":"Azimi","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2020.118291_bb0170","series-title":"Calcium Signal Transduct","article-title":"Alterations in calcium signaling pathways in breast cancer","author":"Dumitru","year":"2018"},{"key":"10.1016\/j.lfs.2020.118291_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/pros.23879","article-title":"T-type calcium channels drive the proliferation of androgen-receptor negative prostate cancer cells","author":"Silvestri","year":"2019","journal-title":"Prostate"},{"key":"10.1016\/j.lfs.2020.118291_bb0180","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1158\/0008-5472.CAN-18-1924","article-title":"T-type Ca v 3.1 channels mediate progression and chemotherapeutic resistance in glioblastoma","volume":"79","author":"Visa","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2020.118291_bb0185","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1158\/0008-5472.CAN-16-2347","article-title":"Targetable T-type calcium channels drive glioblastoma","volume":"77","author":"Zhang","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2020.118291_bb0190","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00424-014-1444-z","article-title":"T-type calcium channels blockers as new tools in cancer therapies","volume":"466","author":"Dziegielewska","year":"2014","journal-title":"Pflugers Arch. - Eur. J. Physiol."},{"key":"10.1016\/j.lfs.2020.118291_bb0195","first-page":"4535","article-title":"Inactivation of CACNA1G, a T-type calcium channel gene, by aberrant methylation of its 5\u2019 CpG island in human tumors","volume":"59","author":"Toyota","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2020.118291_bb0205","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.18632\/oncotarget.24194","article-title":"Cav3.1 overexpression is associated with negative characteristics and prognosis in non-small cell lung cancer","volume":"9","author":"Suo","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2020.118291_bb0210","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1423-0127-17-36","article-title":"Trypsin-induced proteome alteration during cell subculture in mammalian cells","volume":"17","author":"Huang","year":"2010","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.lfs.2020.118291_bb0215","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/pcmr.12690","article-title":"T-type calcium channels drive migration\/invasion in BRAFV600E melanoma cells through Snail1","volume":"31","author":"Maiques","year":"2018","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.lfs.2020.118291_bb0220","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.celrep.2016.04.065","article-title":"Autophagy promotes focal adhesion disassembly and cell motility of metastatic tumor cells through the direct interaction of paxillin with LC3","volume":"15","author":"Sharifi","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.lfs.2020.118291_bb0225","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/156800911794519752","article-title":"Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives","volume":"11","author":"Chen","year":"2011","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.lfs.2020.118291_bb0230","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12013-009-9057-4","article-title":"Positive allosteric interaction of structurally diverse T-type calcium channel antagonists","volume":"55","author":"Uebele","year":"2009","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.lfs.2020.118291_bb0235","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.pain.2012.10.023","article-title":"State-dependent properties of a new T-type calcium channel blocker enhance CaV3.2 selectivity and support analgesic effects","volume":"154","author":"Francois","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2020.118291_bb0240","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.biopsych.2010.05.004","article-title":"T-type calcium channel antagonism decreases motivation for nicotine and blocks nicotine- and cue-induced reinstatement for a response previously reinforced with nicotine","volume":"68","author":"Uslaner","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.lfs.2020.118291_bb0245","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1172\/JCI36954","article-title":"Antagonism of T-type calcium channels inhibits high-fat diet\u2013induced weight gain in mice","volume":"119","author":"Uebele","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2020.118291_bb0250","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.neuropharm.2010.11.015","article-title":"T-type calcium channel antagonism produces antipsychotic-like effects and reduces stimulant-induced glutamate release in the nucleus accumbens of rats","volume":"62","author":"Uslaner","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2020.118291_bb0255","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bios.2019.02.070","article-title":"On-chip anticancer drug screening \u2013 recent progress in microfluidic platforms to address challenges in chemotherapy","volume":"137","author":"Dhiman","year":"2019","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.lfs.2020.118291_bb0260","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4161\/cbt.27148","article-title":"Binding and inhibition of drug transport proteins by heparin: a potential drug transporter modulator capable of reducing multidrug resistance in human cancer cells","volume":"15","author":"Chen","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.lfs.2020.118291_bb0265","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ceca.2019.05.006","article-title":"Calcium channels and cancer stem cells","volume":"81","author":"O\u2019Reilly","year":"2019","journal-title":"Cell Calcium"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520310432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520310432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:53:18Z","timestamp":1777431198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520310432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":51,"alternative-id":["S0024320520310432"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118291","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T-type calcium channel antagonist, TTA-A2 exhibits anti-cancer properties in 3D spheroids of A549, a lung adenocarcinoma cell line","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118291","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"118291"}}